Navigation Links
Drop in cancer deaths tied primarily to gains in behavior and screening
Date:12/2/2008

CAMBRIDGE, Mass., Dec. 2, 2008 Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.

While not the first to report a long-term decline in cancer mortality, Cutler's is the first study to examine the reasons for this decline. Published in the fall edition of the Journal of Economic Perspectives, Cutler's paper, titled "Are We Finally Winning the War on Cancer?", looks at data for lung, colorectal, breast and prostate cancer.

"The decline in cancer is much larger than we commonly understand," says Cutler, who is Otto Eckstein Professor of Applied Economics in Harvard's Faculty of Arts and Sciences, "and thus the benefits to society from reduced cancer mortality are even bigger than previously thought."

Cutler added that it had been unclear which of the many steps that have been taken to fight cancer have been most effective. In this research, he found that while reasons for the decline vary by type of cancer, screening and behavioral changes have contributed both equally and substantially.

Behavioral changes have had the greatest effect on lung cancer, Cutler says, where smoking cessation has had a tremendous impact. Other types of cancer have not been similarly impacted by the reduction in smoking. "The immense effort put into reducing smoking the past few decades has really paid off," Cutler noted.

In contrast, screening has proven especially effective in early detection of colorectal and breast cancer, but less so in identifying lung or prostate cancer. Colonoscopies also have a preventive value in removing polyps, and so preventing the formation of colon cancer.

"Among types of cancer where screening is valuable," Cutler says, "the question becomes: How can we increase the number of people who are being screened? Although costly, many types of screening are an enormous value."

Cutler found that treatment of cancer after its detection has been the least decisive of the three factors in cutting the cancer mortality rate.

"Drugs that are quite expensive have been shown to extend life by only a few months among patients with metastatic cancer, which raises questions about the relative value of such costly treatments," he says. "In contrast, while screening can be expensive, increased screening has led to significantly longer life expectancy for those diagnosed early with colorectal or breast cancer."

Cutler examined these four types of cancer because they are the most common, with abundant data on patient outcomes. Data was examined from population registries of individuals with cancer, as well as clinical literature about the effectiveness of behavioral changes, screenings and treatment.

"We typically think of the war on cancer as developing a new cure," says Cutler. "An equally important question is figuring out how we can take what we know and make it work for more people. We should think about the war as not just developing the next weapon, but using what we have in a smarter way. A health care system working for cancer would prevent people from getting it, catch it early, and then treat people accordingly. If our healthcare sys-tem was focused in this way, there could be a huge benefit."


'/>"/>

Contact: Amy Lavoie
amy_lavoie@harvard.edu
617-496-9982
Harvard University
Source:Eurekalert

Related medicine news :

1. EIN News Introduces Prostate Cancer News Today; Website Offers Information on Risk Factors, Treatment, Drugs
2. EIN News Introduces Lung Cancer News Today; Website Offers Information on Risk Factors, Treatment, Drugs
3. USHIFU Announces First Sonablate(R) HIFU Device in India for Minimally Invasive Prostate Cancer Treatment
4. Preoperative radiation may improve survival rates in advanced rectal cancer patients
5. HER2 levels may aid in treatment selection for metastatic breast cancer
6. CT Colonography Screens for Cancer, Osteoporosis
7. Stanford blood scanner detects even faint indicators of cancer
8. CT Colonography Offers One-Stop Screening for Cancer and Osteoporosis
9. CT colonography offers 1-stop screening for cancer and osteoporosis
10. New mammography technology effective in detecting breast cancer
11. Escape cancer, but age sooner? The dark side of the tumor suppressing process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: